(Q35172323)

6 August 2017

1 reference

title

Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets (English)

1 reference

6 August 2017

0 references

1 reference

1

Angela Vincent

1 reference

6 August 2017

John Bowen

2

1 reference

PubMed ID

12849266

6 August 2017

John Newsom-Davis

series ordinal

3

1 reference

PubMed ID

12849266

6 August 2017

John McConville

series ordinal

4

1 reference

6 August 2017

1 February 2003

1 reference

6 August 2017

1 reference

6 August 2017

2

1 reference

6 August 2017

2

1 reference

6 August 2017

99-106

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

6 August 2017

1 reference

7 January 2021

Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Function of circulating antibody to acetylcholine receptor in myasthenia gravis: Investigation by plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Myasthenia Gravis: Passive Transfer from Man to Mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Autoimmune Response to Acetylcholine Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Acetylcholine receptor antibody in myasthenia gravis: purification and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Humoral immunity in myasthenia gravis: clinical correlations of anti-receptor antibody avidity and titer

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Clinical implementation of anti-acetylcholine receptor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Analysis of false negative results in the immunoassay for anti-acetylcholine receptor antibodies in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Acetylcholine receptor antibodies in myasthenia gravis: use of a qualitative assay for diagnostic purposes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Detection of antibody classes and subpopulations in myasthenia gravis patients using a new nonradioactive enzyme immunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Ocular myasthenia mimicking a one-and-a-half syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Brain stem compression by a giant vertebrobasilar aneurysm mimicking seronegative myasthenia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Myasthenia gravis mimicking stroke in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Single fiber EMG and repetitive nerve stimulation of the same extensor digitorum communis muscle in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Repetitive nerve stimulation of anconeus in the assessment of neuromuscular transmission disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Decremental motor responses to repetitive nerve stimulation in ALS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

[Importance of neuromuscular "jitter" under stimulation in the diagnosis of myasthenia gravis]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

SFEMG in ocular myasthenia gravis diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Electrophysiological findings including single fibre EMG in a family with mitochondrial myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Single fibre EMG findings in polyneuropathies of different aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

A comparison of concentric needle electromyography, quantitative EMG and single fibre EMG in the diagnosis of neuromuscular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

The motor unit in muscular dystrophy, a single fibre EMG and scanning EMG study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Respiratory chain complex-I defect mimicking myasthenia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Edrophonium responsiveness not necessarily diagnostic of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

The complication rate of edrophonium testing for suspected myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Electrophysiological characteristics in seronegative myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Seronegative Myasthenia Gravis: Evidence for Plasma Factor(s) Interfering with Acetylcholine Receptor Function

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Seronegative myasthenia gravis: clinical features, response to therapy and synthesis of acetylcholine receptor antibodies in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Clinical heterogeneity of seronegative myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Seronegative myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Acetylcholine receptor antibodies in juvenile myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Myasthenia gravis in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Plasmapheresis in myasthenia gravis. A survey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Postoperative infection after transsternal thymectomy for myasthenia gravis: a retrospective analysis of 125 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Seronegative generalized myasthenia gravis: low frequency of thymic pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Acetylcholine receptor autoantibody secretion by thymocytes: relationship to myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Antibody-secreting cells to acetylcholine receptor and to presynaptic membrane receptor in seronegative myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Myasthenia gravis and myasthenic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Humoral pathogenesis of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Diaphragmatic myasthenia in mother and child

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Passive transfer of seronegative myasthenia gravis to mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Antifilamin, antivinculin, and antitropomyosin antibodies in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Purified IgG from seropositive and seronegative patients with mysasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Plasma from patients with seronegative myasthenia gravis inhibit nAChR responses in the TE671/RD cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

AChR phosphorylation and indirect inhibition of AChR function in seronegative MG.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in 'antibody-negative' myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Modulation of acetylcholine receptor expression in seronegative myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900306-5

7 January 2021

10.1016/S1474-4422(03)00306-5

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12849266